2026-08-26 | Nationwide cannabis shipping by pharmacies via online platforms such as “Dr. Ansay” is facing criticism due to the lack of personal contact with physicians and promotional product presentations, according to the Thüringer Allgemeine. While the Thuringian Chamber of Pharmacists and the State Office for Consumer Protection are reviewing the practice, the Düsseldorf Regional Court classified the cooperation with pharmacies as anti-competitive. Platform founder Can Ansay defended the model as an important source of care for self-paying patients. However, the German government is already planning to completely ban mail-order sales of cannabis flowers and require personal initial consultations with physicians.
Source German Cannabis Business Assoc
